Press Releases

Enabling flexible adaption to changing requirements for the packaging...

Solida and parenteral blister packs are often produced on monobloc machines designed for specific applications. Format changes are complex and expensive procedures. In packaging medication,...

AGC Biologics Completes PPQ Manufacturing Campaign with Provention Bio...

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), achieved the on-schedule completion of a drug substance Process Performance Qualification (PPQ) campaign,...

Intravacc and Therapyx jointly develop the world’s first prophylactic...

Intravacc, a global leader in translational research and development of viral and bacterial vaccines, has partnered with American, Buffalo, NY, based Therapyx, to further develop...

Trialbee Partners with Clinerion for Expanded Access to Global...

Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, announced a partnership with Clinerion, a worldwide leader in medical data...

Merck’s KEYTRUDA Receives Two New Approvals in Japan

Merck, known as MSD outside the United States and Canada, announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has received two new approvals from the Japan Pharmaceuticals...

Imfinzi approved in Japan for the treatment of extensive-stage...

AstraZeneca’s Imfinzi (durvalumab) has been approved in Japan for the treatment of patients with extensive-stage small cell lung cancer (ES-SCLC), in combination with etoposide plus...

AstraZeneca Phase I clinical trial initiated for COVID-19 monoclonal...

The first participants have been dosed in a Phase I trial of AZD7442, a combination of two monoclonal antibodies (mAbs) in development for the prevention...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read